News
SMMT
3.550
-1.11%
-0.040
These Are The Biotechs Showing Up At The Biggest Cancer Meeting Of The Year (Oral Presentations)
Annual Meeting of the American Society of Clinical Oncology will be held in Chicago. The oral presentations will cover a range of topics including targeted therapies and immunologic therapies for various types of cancer. The plenary session will feature presentations on esophageal cancer, melanoma and lung cancer.
Seeking Alpha · 13h ago
Press Release: Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024
Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024 Conference Call to be Held at 9:00am ET. Summit will host an earnings call to announce its first quarter 2024 financial results and provide an operational update. Summit has begun its clinical development of ivonescimab in non-small cell lung cancer.
Dow Jones · 1d ago
Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024
Summit Therapeutics Inc. Will host an earnings call to announce its first quarter 2024 financial results and provide an operational update on May 1, 2024. Summit will host a live webcast of the earnings conference call at 9:00am ET. Ivonescimab is a potential first-in-class antibody combining the effects of immunotherapy and blocking PD-1 and VEGF into a single molecule. Summit has begun its clinical development of ivones cimab in non-small cell lung cancer.
Barchart · 1d ago
Weekly Report: what happened at SMMT last week (0415-0419)?
Weekly Report · 4d ago
Wall Street Breakfast: The Week Ahead
All eyes will be on the latest U.S. Personal income and outlays report, due Friday. The first quarter earnings season will be dominated by big names like Microsoft and Tesla. Volatility watch: Options trading volume is elevated on Snap and Summit Therapeutics. The world will have its eyes on the World Summit in Dubai.
Seeking Alpha · 5d ago
Catalyst Watch: Tesla, Boeing and General Motors brace for earnings fireworks
Seeking Alpha · 6d ago
Notable Thursday Option Activity: SMMT, MRNA, GME
NASDAQ · 04/18 19:21
Weekly Report: what happened at SMMT last week (0408-0412)?
Weekly Report · 04/15 09:38
Summit Therapeutics Appoints Biotech Veteran to Board
TipRanks · 04/11 20:52
SUMMIT THERAPEUTICS APPOINTS DR. MOSTAFA RONAGHI, RENOWNED EXECUTIVE AND GENOMICIST, TO ITS BOARD OF DIRECTORS
Reuters · 04/11 20:30
Analysts Offer Insights on Healthcare Companies: Avita Medical (RCEL), Summit Therapeutics (SMMT) and Neurocrine (NBIX)
TipRanks · 04/11 11:30
UPDATE 2-Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed
Illumina CFO Joydeep Goswami to depart, former Summit Therapeutics exec Ankur Dhingra to succeed. Gene sequencing company Illumina says he will be succeeded by former Summit executive. Company has reaffirmed its forecast for the first quarter and full-year 2024.
Reuters · 04/09 21:28
UPDATE 1-Illumina CFO Goswami to depart, Summit Therapeutics' Dhingra named successor
Illumina's chief financial officer Joydeep Goswami to leave the gene sequencing company. He will be succeeded by former Summit Therapeutics' Ankur Dhingra. Company reaffirms its forecast for the first quarter and full-year 2024. Illumina's CFO has been with the company since early 2023.
Reuters · 04/09 20:28
CORRECTED-Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra named successor
Illumina says chief financial officer Joydeep Goswami to leave the gene sequencing company. He will be succeeded by former Summit Therapeutics exec Ankur Dhingra, Illumina says. Dhingrra is a former executive at the same company, company says.
Reuters · 04/09 20:18
Weekly Report: what happened at SMMT last week (0401-0405)?
Weekly Report · 04/08 09:40
Summit Therapeutics Announces Major Leadership Restructuring
TipRanks · 04/03 20:52
SUMMIT THERAPEUTICS INC - APPOINTED ITS CHIEF OPERATING OFFICER MANMEET SONI TO OFFICE OF CHIEF FINANCIAL OFFICER
Reuters · 04/03 20:43
Commit To Buy Summit Therapeutics At $3, Earn 24.6% Annualized Using Options
NASDAQ · 04/03 16:26
Weekly Report: what happened at SMMT last week (0325-0329)?
Weekly Report · 04/01 09:39
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Kodiak Sciences shares dipped 19.9% to $5.97 on Thursday. The company reported a wider-than-expected fourth-quarter loss. Avalo Therapeutics, Inc. Shares jumped 430% in today's mid-day session. Other stocks moving in the market include RH, Ggoorks and Xilio.
Benzinga · 03/28 18:08
More
Webull provides a variety of real-time SMMT stock news. You can receive the latest news about Summit Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About SMMT
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. It develops ivonescimab in non-small cell lung cancer (NSCLC), specifically launching Phase III clinical trials in the indications such as ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a third-generation EGFR tyrosine kinase inhibitor (HARMONi), and ivonescimab combined with chemotherapy in first-line metastatic squamous NSCLC patients (HARMONi-3). Its ivonescimab is engineered with Akeso's Tetrabody technology.